Tumor Volume Does Not Predict for Biochemical Recurrence After Radical Prostatectomy in Patients with Surgical Gleason Score 6 or Less Prostate Cancer

Urology

Volumn 70, Issue 2, 2007, Pages 294-298

  Merrill, Megan M ^a   Lane, Brian R ^b   Reuther, Alwyn M ^b   Zhou, Ming ^b   Magi Galluzzi, Cristina ^b   Klein, Eric A ^b  

^a CHRISTIANA CARE HEALTH SYSTEM   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CORRELATION ANALYSIS; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 34548388035     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2007.03.062     Document Type: Article

References (13)

1. Stamey T.A., McNeal J.E., Yemoto C.M., et al. Biological determinants of cancer progression in men with prostate cancer. JAMA 281 (1999) 1395-1400
2. Kattan M.W., Wheeler T.M., and Scardino P.T. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 17 (1999) 1499-1507
3. Epstein J.I., Amin M., Boccon-Gibod L., et al. Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimens. Scand J Urol Nephrol Suppl 216 (2005) 34-63
4. Olumi A.F., Richie J.P., Schultz D.J., et al. Calculated volume of prostate cancer identifies patients with clinical stage T1c disease at high risk of biochemical recurrence after radical prostatectomy: a preliminary study. Urology 56 (2000) 273-277
5. Stephenson A.J., Scardino P.T., Eastham J.A., et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23 (2005) 7005-7012
6. Stamey T.A., Freiha F.S., McNeal J.E., et al. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71 (1993) 933-938
7. Epstein J.I., Carmichael M., Partin A.W., et al. Is tumor volume an independent predictor of progression following radical prostatectomy?. A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol 149 (1993) 1478-1481
8. Renshaw A.A., Chang H., and D'Amico A.V. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol 107 (1997) 704-708
9. Catalona W.J., Smith D.S., Ratliff T.L., et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270 (1993) 948-954
10. Ramos C.G., Roehl K.A., Antenor J.A., et al. Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer. J Urol 172 (2004) 137-140
11. Kikuchi E., Scardino P.T., Wheeler T.M., et al. Is tumor volume an independent prognostic factor in clinically localized prostate cancer?. J Urol 172 (2004) 508-511
12. Nelson B.A., Shappell S.B., Chang S.S., et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 97 (2006) 1169-1172
13. Cheng L., Koch M.O., Juliar B.E., et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol 23 (2005) 2911-2917